Analysis
OpenAI has proposed handing the US government a 5% stake in the company as it works to defuse mounting political pressure in Washington, the Financial Times reported and CNBC confirmed on July 2. At OpenAI's $852 billion valuation from its record-breaking March funding round, a 5% holding would be worth roughly $42.6 billion.
Sam Altman has argued the move is the best way to share AI's upside with the public, according to people familiar with the discussions, and has compared the idea to Alaska's Permanent Fund -- the sovereign vehicle that invests the state's oil wealth and pays residents annual dividends. Altman reportedly raised a stake of this size directly with President Trump, Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick, floating a broader arrangement where Washington would hold 5% of each leading US AI company, not just OpenAI.
“The precedent here is the US government's 10% stake in Intel, taken in August for $8.9 billion under a CHIPS Act-linked rationale.”
The precedent here is the US government's 10% stake in Intel, taken in August for $8.9 billion under a CHIPS Act-linked rationale. OpenAI's situation is different: there's no comparable domestic-manufacturing subsidy driving the conversation, which makes the offer read more like a hedge against future regulatory or antitrust action than a negotiated industrial-policy deal.
For founders and operators, the signal is that being classified as 'critical AI infrastructure' now carries a real cost of admission -- equity, not just compliance paperwork -- and that cost is being set by the largest labs first. For GPs evaluating AI-adjacent bets, government equity stakes introduce a new category of stakeholder whose incentives (political optics, national-security framing) don't always align with existing investors' return timelines.
What to watch: whether the Trump administration formally accepts the offer or treats it as one data point in a broader AI-oversight push, and whether Anthropic, Google DeepMind or xAI face pressure to make similar overtures once one frontier lab has set the precedent.